Debt-to-equity of Tyra Biosciences, Inc. from 30 Jun 2022 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tyra Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 31 Dec 2025.
  • Tyra Biosciences, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 7.2%, a 52% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Tyra Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 7.2% +2.5% +52% 31 Dec 2025
Q3 2025 6.5% +1.2% +21% 30 Sep 2025
Q2 2025 5.9% +0.07% +1.2% 30 Jun 2025
Q1 2025 5.3% -0.73% -12% 31 Mar 2025
Q4 2024 4.8% -1.3% -22% 31 Dec 2024
Q3 2024 5.3% +0.97% +22% 30 Sep 2024
Q2 2024 5.8% +2.4% +71% 30 Jun 2024
Q1 2024 6.1% +3.1% +106% 31 Mar 2024
Q4 2023 6.1% +3.1% +104% 31 Dec 2023
Q3 2023 4.4% +1.8% +70% 30 Sep 2023
Q2 2023 3.4% +1.1% +47% 30 Jun 2023
Q1 2023 3% 31 Mar 2023
Q4 2022 3% 31 Dec 2022
Q3 2022 2.6% 30 Sep 2022
Q2 2022 2.3% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.